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Objective: The aim of this study was to compare the responsiveness of various patient-reported outcome
measures (PROMs) and clinician-reported outcomes following total knee arthroplasty (TKA) over a 2-
year period.
Methods: Data were collected in a prospective cohort study of primary TKA. Patients who had completed
Forgotten Joint Score-12 (FJS-12), Western Ontario and McMaster Universities (WOMAC) osteoarthritis
(OA) index, EQ-5D, Knee Society Score and range of movement (ROM) assessment were included. Five
time points were assessed: pre-operative, 2 months, 6 months, 1 year and 2 years post-operative.
Results: Data from 98 TKAs were available for analysis. Largest effect sizes (ES) for change from pre-
operative to 2-month follow-up were observed for the Knee Society Score (KSS) Knee score (1.70) and
WOMAC Total (1.50). For the period from 6 months to 1 year the largest ES for change were shown by
the FJS-12 (0.99) and the KSS Function Score (0.88). The EQ-5D showed the strongest ceiling effect at 1-
year follow-up with 84.4% of patients scoring the maximum score. ES for the time from 1- to 2-year
follow-up were largest for the FJS-12 (0.50). All other outcome measures showed ES equal or below 0.30.
Conclusion: Outcome measures differ considerably in responsiveness, especially beyond one year post-
operatively. Joint-speciﬁc outcome measures are more responsive than clinician-reported or generic
health outcome tools. The FJS-12 was the most responsive of the tools assessed; suggesting that joint
awareness may be a more discerning measure of patient outcome than traditional PROMs.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The outcomes of total knee arthroplasty (TKA) can be assessed
with various methods; implant survivorship, image-based assess-
ment, clinical assessment and patient-reported outcome measures
(PROMs). While the ﬁrst three modalities are objective in nature,
patient report can provide a subjective measure of the patients’
perception of the success of an intervention.
The importance of including patients’ views on treatment
outcome in orthopaedics has been well established in recent years
and a variety of patient-reported measures are available1. Further-
more self-reported questionnaires are a potentially cost-effectiveJ.M. Giesinger, Department of
rlands Cancer Institute, Ples-
(K. Giesinger), d.f.hamilton@
st), bernhard.holzner@uki.at
singer).
s Research Society International. Pway of monitoring patient outcome in large volumes. PROMs can
be broadly dichotomised into generic health status questionnaires
such as theEQ-5Dor SF-36 (that assess the individuals overall quality
of life) and disease/joint-speciﬁc tools such as the Western Ontario
and McMaster Universities (WOMAC) score which focus on speciﬁc
constructs such as pain, stiffness and joint function in activities of
daily living2. These latter examples allow a more focused evaluation
of an intervention such as TKA. The most common orthopaedic
patient-reported outcome (PRO) tools have been extensively ana-
lysed regarding their validity and reproducibility3e5. More recently
researchers have turned to assess the responsiveness and ﬂoor/
ceiling effects6,7. Responsiveness to change is of particular impor-
tance in longitudinal studies where the scoring should reﬂect
changes over time. If a questionnaire is not sufﬁciently responsive to
theconstructbeing assessed, itwill not capture changes at follow-up,
which is especially important in mid-to-long-term studies where
changes in the patients’ pain and function are typically not as pro-
nounced as in the early post-operative phase. This is of direct rele-
vance to measuring PRO following TKA where patient functionublished by Elsevier Ltd. All rights reserved.
Table I
Patient characteristics at baseline (pre-operatively, n ¼ 98)
Age Mean (SD) 68.1 (8.6)
Range 49e80
Sex Men 51.0% N ¼ 50
Women 49.0% N ¼ 48
Side Left 49.0% N ¼ 48
Right 51.0% N ¼ 50
BMI Mean (SD) 28.8 (4.5)
Range 19e41
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by more subtle changes over time8.
Previous studies of instrument responsiveness however tended
to focus on comparison of general health measures vs joint-speciﬁc
measures6,9 or covered follow-up only up to 12 months10e13.
Comprehensive analyses of multiple outcome assessment tools at
various time points over 2 years are lacking.
The aim of this study is to compare the responsiveness of
various PROMs (FJS-12, WOMAC score, EQ-5D) and clinician-
reported outcomes (Knee Society Score, range of motion)
following TKA.
Patients and methods
Sample population
Datawere collected in a prospective cohort study of primary TKA
between 2007 and 2009 at Kantonsspital St. Gallen, Switzerland.
This was a pragmatic study that reﬂected local surgical practice at
the time using both, mobile and ﬁxed bearing designs. Informed
consent was obtained from the participants and ethical approval
was granted by the local ethics committee. Patients who had
completed FJS-12, WOMAC score, EQ-5D and Knee Society Score
(KSS) were included. Participants were assessed at ﬁve different
time points: pre-operatively, and at 2, 6, 12 and 24 months post-
operatively. Socio-demographic and clinical data included gender,
Body Mass Index (BMI), age at time of surgery and side of implant.
Outcome measures
A single experienced study performed the clinical examinations
and handed over the questionnaires to the patients who completed
them independently.
WOMAC
WOMAC osteoarthritis (OA) index is a widely used self-report
outcome measure in patients with lower limb OA that was intro-
duced by Bellamy and Buchanan14. The original score with 5-point
Likert response categories consists of 24 questions covering three
dimensions: pain (ﬁve questions), stiffness (two questions), and
function (17 questions). The WOMAC has been extensively tested
for validity, reliability, feasibility, and responsiveness for measuring
changes after different OA interventions14e17 and has also been
evaluated in an electronic form18. WOMAC scores were linearly
transformed to a 0e100 scale with higher scores indicating more
severe impairment.
Forgotten Joint Score (FJS-12)
The FJS-12 is a recently published PRO scale to assess joint
awareness in hips and knees during various activities of daily
living19,20. It uses a 5-point Likert response format, consisting of
12 equally weighted questions with the raw score transformed to
range from 0 to 100 points. High scores indicate good outcome, i.e.,
a high degree of being able to forget about the affected joint in daily
life. In its validation study19 it showed a low ceiling effect and high
internal consistency (Cronbach’s Alpha 0.95) and discriminated
well between patient groups known to show different outcome.
EQ-5D
The EQ-5D is a standardised generic quality of life assessment
instrument with ﬁve items for use as a measure of self-reported
general health21. Applicable to a wide range of health conditions
and treatments, it provides a simple descriptive proﬁle and a single
index value for health status. It is one of the internationally most
frequently used measures to gain quality of life scores for analysis inhealth economics as utility weights (ranging from 0 to 1) for calcu-
lating quality of life adjusted life years (QALYs) can be obtained22.
KSS
The KSS23 is a widely used clinician-reported outcome score
with good published validity data24. The clinical part (Knee Score)
of the KSS covers pain, range of movement (ROM), alignment and
stability. The functional part (Function Score) of the KSS covers the
patient’s mobility (walking distance and stairs) and potential
walking aids. Score range of the KSS is from 0 to 100 points for each
part with higher scores indicating less severe impairment.
ROM
Active measures of ﬂexion and extension were determined us-
ing universal goniometry. A high level of accuracy has been previ-
ously demonstrated assessing knee range of motion with this
instrument in the clinical setting25 and speciﬁcally in this patient
group26. All measurements were made by the study nurse.
Statistical analysis
Sample characteristics are given as means, standard deviations
(SDs), ranges, and frequencies. As measures of responsiveness we
provide effect sizes (ES, mean difference divided by SD at earlier
assessment), standardised response means (SRMs, mean change
divided by the standard deviation of the change score) and relative
validity (RV). RVwas obtained from the ratio of the F-statistics from
an analysis of variance for repeated measures, comparing two time
points. As a reference measure (the denominator) we used the
WOMAC total scale for all time points. In addition, we provide
percentages of patients obtaining the highest or the lowest possible
score on a measure (i.e., ﬂoor and ceiling effects). Statistical ana-
lyses were performed with SPSS 20.0.
Results
Patient characteristics
During the study period 537 patients underwent TKA at our
institution. Our part-time study nurse recruited 98 of these for the
study. Mean age at baseline was 68.1 years (SD 8.6), 49% were fe-
male (Table I). The number of subjects for whom data was available
varied according to the different time points as shown in Table II. All
available data points were included in the analyses.
Responsiveness over time
To highlight how the different measures perform over different
time-intervals following surgery we analysed data by investigating
responsiveness compared to baseline and also to the previous
follow-up assessment. Presenting responsiveness indices this way
allows to demonstrate more clearly at which time point after sur-
gery the various measures are able to capture change. Baseline
comparisons are also detailed in the Tables III and IV.
Table II
Descriptive statistics of outcome measures
Pre-surgery 2 Months 6 Months 1 Year 2 Years
Mean SD N Mean SD N Mean SD N Mean SD N Mean SD N
EQ-5D (UK) 0.56 0.28 96 0.81 0.23 93 0.89 0.22 95 0.94 0.19 96 0.94 0.17 91
FJS-12* e e 20.9 17.4 87 41.7 25.9 90 67.3 27.2 94 80.8 25.8 91
WOMAC pain 47.4 16.0 91 23.1 13.6 92 13.7 10.0 91 6.8 8.7 96 4.6 9.1 91
WOMAC stiffness 49.3 30.3 88 24.9 22.0 92 12.2 14.2 91 7.8 12.6 96 4.4 11.1 91
WOMAC function 49.5 17.0 90 27.0 14.7 92 16.0 11.9 91 6.9 9.1 96 4.3 8.0 91
WOMAC total 48.4 14.9 87 26.0 13.8 92 15.2 10.5 91 6.9 8.6 96 4.4 8.0 91
ROM 112.2 22.2 97 107.9 11.8 97 114.6 15.1 95 120.4 9.8 96 120.8 9.8 90
KSS knee score 49.4 17.6 77 79.3 10.5 78 84.8 10.2 86 91.7 8.3 88 93.7 9.2 85
KSS function score 67.4 15.6 77 57.4 16.5 78 77.2 13.9 86 89.5 13.6 88 88.9 13.6 85
* Not administered pre-operatively.
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Largest ES for change from pre-operative to 2-month follow-up
were observed for the KSS knee score (1.70), WOMAC-pain (1.52)
and WOMAC total (1.50). In contrast, range of motion only
changed little with an ES of 0.19. SRM was biggest for WOMAC
pain (1.18) and WOMAC function (0.91) and smallest for ROM
(0.20). At baseline, only WOMAC stiffness showed ﬂoor and
ceiling effects with 12.4% of the patients obtaining the lowest
possible score and 14.6% the highest possible score. At 2-months
follow-up most pronounced ﬂoor and ceiling effects were
observed for the EQ-5D (39.4% highest score) and again WOMAC
stiffness (29.0% lowest score). Score change of the FJS-12 could not
be calculated as this score was not administered pre-operatively.
Further details are given in Tables IIeV.
2-Month to 6-month follow-up
From 2-month to 6-month follow-up the biggest change in
terms of ES was found for the FJS-12 and the KSS function score
(both 1.20). The KSS knee score (0.52) and the EQ-5D (0.37) showed
the smallest change for this period. SRMwas smallest for the EQ-5D
(0.35) and biggest for the KSS function score (1.14) and theWOMAC
total score (0.86). At 6-month follow-up the most pronounced
ﬂoor and ceiling effects were found for the EQ-5D (67.4% highest
score), the WOMAC stiffness score (51.6%) and the KSS function
score (14.6% highest score). Further details are given in Tables IIeV.
6-Month to 1-year follow-up
For the period from 6 months to 1 year the greatest ES for
change were shown by the FJS-12 (0.99) and the KSS function score
(0.88). The FJS-12 was also the largest in terms of SRM (0.99), fol-
lowed by theWOMAC function and total score (both0.90) and the
KSS function score (0.89). Again the EQ-5D and the WOMACTable III
ES of outcome measures
Pre-surgery e
2 months
Pre-surgery e
6 months
Pre-surgery e
1 year
N ES N ES N ES
EQ-5D (UK) 93 0.87 95 1.18 96 1.36
FJS-12* e e e e e e
WOMAC pain 91 1.52 91 2.11 91 2.54
WOMAC stiffness 88 0.81 88 1.22 88 1.37
WOMAC function 90 1.32 90 1.97 90 2.51
WOMAC total 87 1.50 87 2.23 87 2.79
ROM 97 0.19 95 0.11 96 0.37
KSS knee score 77 1.70 77 2.01 77 2.40
KSS function score 77 0.64 77 0.63 77 1.42
* Not administered pre-operatively.stiffness score performed worst with regard to ES and SRM. These
two scores also showed the strongest ﬂoor and ceiling effects at 1-
year follow-up (EQ-5D 84.4% highest score and WOMAC stiffness
64.6% lowest score). At this time point the FJS-12 was the only score
that had less than 10% in the highest or lowest category. Further
details are given in Tables IIeV.
1e2-year follow-up
ES for the time from 1- to 2-year follow-up were biggest for the
FJS-12 (0.50). All other scores showed ES equal or below 0.30. SRM
was highest for theWOMAC Total score (0.31) and the FJS-12 (0.30).
ROM remained constant at a mean of 120 showing no ceiling effect
as TKA patients’ ROM is naturally less than a healthy individual’s
ROM. All other outcome measures showed substantial ﬂoor and
ceiling effects. The FJS-12 had 33.0% of patients showing the highest
score followed by the KSS Knee score (37.6%) and theWOMAC Total
score (39.6%). Further details are given in Table IIeV.
Discussion
This study demonstrates that outcome measures widely used in
orthopaedic research differ substantially with regard to their
responsiveness. Previous authors have highlighted differences be-
tween various tools, however have focused on early outcome,
typically comparing two instruments ability to assess change over
6e12 months post-operatively10e13,27.
Complicating outcome assessment interpretation is the fact that
the various scores have differing (sometimes substantial) ceiling
effects, e.g., they are not capturing change due to a lack of
discriminatory power of the scores as opposed to a lack of change.
A particular strength of this study is the comprehensive
assessment of various outcome tools over ﬁve time points, which
allows a more detailed analysis of the behaviour of the different
tools into the later recovery phase. There is scant data on PROMPre-surgery e
2 years
2 Monthse6
months
6 monthse1
year
1 Yeare2 years
N ES N ES N ES N ES
91 1.36 93 0.37 95 0.21 91 0.02
e e 87 1.20 90 0.99 91 0.50
91 2.68 91 0.69 91 0.69 91 0.25
88 1.48 91 0.57 91 0.31 91 0.27
90 2.66 91 0.75 91 0.76 91 0.29
87 2.95 91 0.79 91 0.78 91 0.30
90 0.39 95 0.56 95 0.38 90 0.04
77 2.52 78 0.52 86 0.68 85 0.24
77 1.38 78 1.20 86 0.88 85 0.04
Table IV
SRM and RV of outcome measures
Pre-surgery e
2 months
Pre-surgery e 6
months
Pre-surgery e
1 year
Pre-surgery e
2 years
2 Monthse6
months
6 Monthse1
year
1 Yeare2 years
SRM RV SRM RV SRM RV SRM RV SRM RV SRM RV SRM RV
EQ-5D (UK) 0.69 0.32 1.16 0.33 1.13 0.20 1.11 0.22 0.35 0.34 0.19 0.03 0.14 0.07
FJS-12* e e e e e e e e 0.84 0.94 0.99 1.01 0.30 3.27
WOMAC pain 1.18 1.19 2.04 0.98 2.41 0.86 2.33 0.93 0.78 0.79 0.65 0.56 0.27 0.78
WOMAC stiffness 0.53 0.27 1.05 0.25 1.24 0.22 1.36 0.31 0.48 0.24 0.25 0.06 0.26 0.80
WOMAC function 0.91 0.83 1.93 0.87 2.45 0.88 2.33 0.92 0.81 0.90 0.90 0.97 0.29 0.81
WOMAC totaly 0.87 1.00 2.10 1.00 2.65 1.00 2.47 1.00 0.86 1.00 0.90 1.00 0.31 1.00
ROM 0.20 0.03 0.05 <0.01 0.37 0.02 0.42 0.03 0.15 0.37 0.41 0.19 0.25 <0.01
KSS knee score 1.53 1.02 1.70 0.54 2.15 0.55 2.40 0.78 0.52 0.26 0.84 0.57 0.17 0.25
KSS function score 0.52 0.12 0.73 0.10 1.23 0.18 1.08 0.16 1.14 1.26 0.89 0.64 0.09 0.08
* Not administered pre-operatively.
y Reference measure (denominator) for calculating RV.
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Browne et al.28 suggested to follow-up patients until 1 year post-
operatively, our data demonstrate the need of longer follow-up
periods. We captured change between 12 and 24 months using
responsive measures. The need for follow-up beyond one year has
been recognised and is also reﬂected by journal author
guidelines29. It is of note that orthopaedic journal author guidelines
started to require 2-year outcome data for clinical studies involving
new implants despite the fact that the ability of various PROMs
to capture change over this time frame still needs further
investigation.
The sex ratio we report in this study was unexpectedly equal,
however, this reﬂects the patient throughput in our clinics on the 2
days/week the study nursewas present to recruit. To check that this
had no confounding effect on our study ﬁndings we compared
weighted and unweighted ES of the measures. We weighted the
study cohort to reﬂect the sex ratio from our local arthroplasty
database (59.8% female) and calculated the difference. This did not
inﬂuence the results presented in the manuscript and we can
therefore be conﬁdent in the analysis presented.
The joint-speciﬁc scores (WOMAC score and the FJS-12) showed
the highest responsiveness in terms of ES and SRMs compared to
the KSS or the EQ-5D. The KSS and ROM measurement was able to
detect change up to 1 year follow-up. However, the KSS barely
improved (1.4 points) between the 1 and 2-year follow-up and ROM
remained constant at 120 (Table II). The two parts of the KSS (Knee
and function score) also showed limited responsiveness in terms of
ES and SRM between 1- and 2-year follow-up but performed sub-
stantially better during the ﬁrst post-operative year. The decreasing
function score of the KSS from pre-operatively to 2 months post-
operatively is mainly due to the use of walking aids. The KSS isTable V
Floor and ceiling effects of outcome measures
Pre-surgery 2 Months
Floor/Ceiling effects* Floor Ceiling Floor Ceiling
EQ-5D (UK) 0.0 0.0 0.0 39.4
FJS-12y e e 8.0 0.0
WOMAC pain 0.0 0.0 2.2 0.0
WOMAC stiffness 12.4 14.6 29.0 2.2
WOMAC function 0.0 0.0 1.1 0.0
WOMAC total 0.0 0.0 1.1 0.0
Range of motionz e e e e
KSS knee score 0.0 0.0 0.0 0.0
KSS function score 0.0 3.8 0.0 1.3
* Percentages for lowest (ﬂoor) and highest (ceiling) possible score on a scale.
y Not administered pre-surgery.
z Concept of ﬂoor and ceiling effect not applicable.very sensitive to this question by subtracting 20 points if crutches
are used. However, at our hospital we often recommend crutches to
elderly patients for 2 months for safety reasons (especially in
winter) so this may well have skewed the KSS in our study. McKay
et al.30 investigated the responsiveness of PROMs and objective
measures pre-operatively and 6 weeks post-operatively in knee OA
patients. For the WOMAC function scale these authors reported a
very similar ES (1.17) and SRM (0.90) for post-operative change at 6-
week follow-up as found in our study. For objective measures ES
were considerably smaller (ﬂat surface walking test 0.38, stair
ascent/descent 0.52, and quadriceps strength 0.68).
In this study, the EQ-5D performed very poorly in terms of
responsiveness, which is related to the vast ceiling effect from 6-
months follow-up onwards (e.g., 84.4% of the patients had the
highest possible score at 1-year follow-up, Table V). Similarly, Ko
et al.6 found better responsiveness of joint-speciﬁc measures in TKA
patients compared to the generic SF-36, and the clinician-reported
KSS. These results highlight the importance of the disease/joint-
speciﬁc PROMs for orthopaedic outcome research as they provide
a valuable means to sensitively capture changes in patient’s con-
dition especially once the post-operative rehabilitation phase has
been completed.
However, joint-speciﬁc measures also show different respon-
siveness. Theiler et al.12 compared the WOMAC with the clinician-
reported Lequesne algo-functional index at baseline, 6 and 12
months in patients undergoing total hip arthroplasty (THA) and
TKA and found superior responsiveness of the patient-reported
WOMAC score. In a recent study Williams et al.7 compared
responsiveness of the WOMAC, the Knee Outcome Survey e Ac-
tivities of Daily Living Scale (ADLS) and the Lower extremity
Functional Scale (LEFS) in patients with knee OA participating in a6 Months 1 Year 2 Years
Floor Ceiling Floor Ceiling Floor Ceiling
0.0 67.4 0.0 84.4 0.0 81.3
4.4 0.0 0.0 3.2 2.2 33.0
7.7 0.0 41.7 0.0 65.9 0.0
51.6 0.0 64.6 0.0 82.4 0.0
1.1 0.0 20.8 0.0 49.5 0.0
1.1 0.0 15.6 0.0 39.6 0.0
e e e e e e
0.0 4.7 0.0 27.3 0.0 37.6
0.0 14.6 0.0 53.4 0.0 47.1
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programme). In contrast to our study TKA was an exclusion crite-
rion and patients were in a better condition (baselineWOMAC total
score was 28.1 points vs pre-operativeWOMAC total score was 48.4
points in our study). When comparing their baseline with 2-month
follow-up ES for change were 0.33 for the ADLS, 0.32 for the LEFS
and 0.43 for theWOMAC (values we have calculated from summary
tables in their manuscript). This suggests that in patients with a
lower symptom burden, the responsiveness of these speciﬁc
outcome measures is poor. Similarly, in the later post-operative
phase after TKA in our study, ES for change were low for the
WOMAC score (0.30 between 1 and 2 years follow-up). The FJS-12
was more responsive with an ES of 0.50 in that time period.
Generic scores such as the EQ-5D failed to detect change after
the early rehabilitation phase since 81% TKA patients report good
outcomes following surgery8,31. Therefore joint-speciﬁc PROMs are
needed to capture change over time or to pick up differences be-
tween two groups in a cross-sectional study design. The FJS-12, a
measure of patients’ joint awareness during activities of daily
living, performed best with regard to ES of changes between from 2
and 6-months, 6 and 12months and between 1 and 2-years follow-
up (Table III). From a logistical and patient compliance point of
view, it is notable that these advantageous measurement charac-
teristics accompany a low number of questions asked.
In most of the outcome measures (WOMAC, ROM, KSS) SD
decreased over time (halving between pre-op assessment and 2-
year follow-up). This is very important in the interpretation of ES,
as the SD is the denominator. In the early recovery phase, ﬂoor/
ceiling effects are less pronounced because data are more normally
distributed. This results in larger SDs (ES denominator). Thus, the
same mean difference results in lower ES in the early recovery
phase compared to the later phase. It is critical to consider this
statistical artifact (which affects SRM in a similar manner) when
interpreting the results in Table IV.
Beyond ES, RV allows for comparative analysis of individual
scores. According to Fayers and Hays32 RV gives the ratio of sample
sizes “that would be required to detect the known group difference
using one measure versus the other”. Therefore RV allows compar-
ison of sample size needed for each instrument. Our data highlight
that the EQ-5D requires 5 times as many patients as the WOMAC
score to demonstrate baseline to 1-year change. It requires 10
times the number of patients compared to the WOMAC score to
capture change between 1 and 2 years post-operatively. For longer
term follow-up (2 years) the FJS-12 requires only one third of the
number of patients compared to the WOMAC score. These are
important considerations when powering outcome studies with
PROMs.
The good responsiveness to change of the FJS-12 is perhaps
because this score is based on a more discerning construct. A
‘forgotten joint’ (i.e., that the patient has no awareness of the
affected joint during various activities of daily living) is very hard to
accomplish. The relatively large ES of this score at 1- and 2-year
follow-up are beneﬁcial with regard to powering outcome studies
over a longer time span, as substantial ﬂoor and ceiling effects
compromise responsiveness.
Conclusion
Outcome measures differ considerably in responsiveness,
especially beyond one year post-operatively (i.e., when comparing
scores at 1- and 2-year follow-up). Joint-speciﬁc self-reported
outcome measures are more responsive than clinician-reported
or generic health outcome tools. The FJS-12 was the most respon-
sive tool assessed. This suggests that joint awarenessmay be amore
discerning measure of patient outcome than traditional PROMs.Author’s contributions
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